Jaime Rosenberg

During the 60th American Society of Hematology Annual Meeting & Exposition held December 1-4 in San Diego, California, Norman Sharpless, MD, director, National Cancer Institute (NCI), brought attention to several advances made in hematologic malignancies over the past year and highlighted 4 areas of focus going forward.

The 2018 Consumer Perspectives on How Social Determinants Impact Clinical Experience report found that 68% of Americans have at least 1 social determinant challenge and the majority do not discuss their challenges with their provider or insurance company.

The project will initially focus on improving patient outcomes for 2 conditions: osteoporosis and migraine.

With $5 million appropriated from Congress, CDC is launching a National Neurological Conditions and Surveillance System to help increase understanding of neurological disorders and to further support neurologic research, starting with multiple sclerosis and Parkinson disease.

A panel of patient advocates at the National Comprehensive Cancer Network Patient Advocacy Meeting, held in Washington, DC, discussed the reasons behind and consequences of inequities in cancer care.

The National Institutes of Health (NIH) said that it will fund a series of collaborations with medical research institutions in the region as part of a new initiative that will expand ongoing research at the NIH-funded Centers for AIDS Research, a group of HIV-focused research institutions focused on reducing the burden of HIV domestically and globally.

Following failure with ruxolitinib, there are limited treatment options available and among these patients who fail on the treatment, prognosis is unfavorable, particularly among those who started ruxolitinib with advanced stage disease, according to a study presented at the 60th American Society of Hematology Annual Meeting & Exposition.

According to a study presented at the 60th American Society of Hematology Annual Meeting & Exposition, held December 1-4 in San Diego, California, a World Health Organization–defined diagnosis of primary myelofibrosis may help better identify patients who may need strict monitoring during treatment with ruxolitinib.

In a new commentary, scientists from the National Institutes of Health (NIH) assert that engaging men in HIV prevention and care is essential for ending the HIV pandemic.

Researchers at the 60th American Society of Hematology Annual Meeting & Exposition presented long-term study results showing that high rates of minimal residual disease–negative complete response were sustained with a median duration of over 4 years among treatment-naïve patients with multiple myeloma.

New research finds migraine with aura is associated with an increased risk of atrial fibrillation (AF), which may help provide a clearer picture of the relationship between the migraine subtype and cardioembolic stroke, as AF is a common source of cardioembolic stroke.

In 2016, 15.4% of physicians worked in practices that used telemedicine for a wide spectrum of patient interactions, including e-visits, and 11.2% of physicians worked in practices that used telemedicine for interactions between physicians and healthcare professionals.

New clinical guidelines are providing guidance for clinicians on the diagnosis, prevention, and treatment of febrile neutropenia in adult patients with solid tumors.

As the world observes World AIDS Day 2018 on December 1, WalletHub has released an HIV/AIDS report in an effort to increase awareness about the virus.

According to a new study, prior migraine history is associated with brain tumors. While associated with both sexes, the risk is higher among men than women.

While team-based approaches to primary care transformation provide benefit to patients with chronic illness by reducing acute care utilization, it may lead to higher use among healthier patients.

From December 1-4, hematology professionals from across the globe will convene in San Diego, California for the American Society of Hematology annual meeting to present and discuss their research and latest developments in malignant and non-malignant hematology. Here’s what to look out for during the meeting.

The US Preventive Services Task Force (USPSTF) is recommending that clinicians offer the treatment to people at high risk of HIV, which will likely increase access to the treatment for those who need it most.

The Kentucky Cabinet for Health and Family Services announced Tuesday that the newly approved program can begin as soon as April 1, 2019, and will be phased in regionally over several months.

During a case study, employees were more willing to have less robust coverage in areas like dental, vision, and diagnostic benefits so that the group could have access to more comprehensive mental health and maternity services.

According to a new study, cellular proliferation generates the majority of infected cells during antiretroviral therapy (ART), suggesting that reducing proliferation can decrease the size of the HIV reservoir and work toward a cure.

Following treatment with either a lifestyle intervention or migraine education, patients with migraine had improved pain acceptance and lower migraine-related disability.

The quick sequential (sepsis-related) organ failure assessment can help emergency department physicians identify which patients with neutropenia are at risk of a poor prognosis and should receive prompt empirical antimicrobial therapy, according to a new study.

A report assessing healthcare utilization and cost patterns in 6 regions across the United States highlighted stark differences in average healthcare costs, with Maryland falling 20% below the average and Colorado landing 19% above average.

One-third of neutropenic patients developed invasive infection following intensive chemotherapy, which was significantly associated with an increase in mortality up to 100 days after the start of neutropenia.

As physicians have an essential role in the fight against HIV—leading patients through the care continuum—understanding HIV-related stigma among physicians can inform development of interventions to reduce this stigma and promote positive clinical outcomes.

As a result of increased prevention and improved medical treatment of cardiovascular disease (CVD), and despite increasing rates of obesity and diabetes, cancer has gradually surpassed CVD as the leading cause of death in high-income counties. However, CVD is more likely to be the leading cause of death in low-income counties.

Between 1999-2000 to 2014, the use of IV fluids, dopaminergic receptor antagonists prochlorperazine/metoclopramide, ketorolac, and dexamethasone increased while the use of narcotics decreased.

A survey of nearly 700 people, each with at least $35,000 in household income, found that more than half of respondents are concerned about their ability to pay a medical bill of less than $1000, with 35% being concerned about paying a medical bill under $500.

Preliminary data from a new study has demonstrated that pre-emptive administration of pan-genotypic, direct-acting antiviral therapy prevents hepatitis C virus (HCV) infection in HCV-negative cardiac transplant patients receiving donor hearts infected with the virus.